{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:26:19Z","timestamp":1793885179106,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The incidence of intracranial germ cell tumors (iGCTs) in adolescents and young adults (AYA) is lower than that in pediatric patients. However, the recurrence rate of iGCT in AYA patients (7.6%) is higher than in children (2%). The use of iGCTs in the AYA population lacks randomized trials to standardize treatment. Therefore, this study aimed to determine the patterns of practice and outcomes of iGCT in AYA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective cohort study iGCT patients aged 15 to 39 who were treated at Siriraj Hospital, Thailand, from 2007 to 2019. The patients' charts were reviewed, and the results were compared between those who received chemotherapy combined with radiotherapy (Chemo-RT) and those who received RT alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median follow-up time was 7.6 years. Eighty-four patients were included in this study: 60 with germinomas and 24 with nongerminomatous germ cell tumors (NGGCT). In the case of NGGCT, the 10-year event-free survival (EFS) and overall survival (OS) were 100% and 100%, respectively, with RT alone. For Chemo-RT, the 10-year EFS was 54.05%, and the 10-year OS was 68.44% (P\u2009=\u20090.640 for EFS and 0.454 for OS). For germinomas, the 10-year EFS was 76.87% with RT alone, and the 10-year OS was 86.40%. For Chemo-RT, the 10-year EFS was 69.63%, and the 10-year OS was 69.63% (P\u2009=\u20090.335 for EFS and 0.022 for OS). Compared with those in the groups treated with Chemo-RT and RT alone adjusted for age\u2009&gt;\u200918\u00a0years, primary site, metastasis, type of surgery, field of radiotherapy, sex, serum beta-HCG, and serum AFP, the hazard ratio (HR) of EFS was 2.49 (0.85\u20137.29) (P\u2009=\u20090.095) and the OS was 2.55 (P\u2009=\u20090.237).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>To the best of our knowledge, we present findings on the outcomes of iGCT patients in the AYA age group. After adjusting the hazard ratio, we found no significant difference between patients who received chemotherapy and those who underwent radiotherapy alone in terms of event-free survival and overall survival. Standardized long-term term survival follow-up and supportive treatment in AYA group is needed to improve the outcome and minimize toxicity in this group. There is a need for further randomized control trials that specifically address the population of patients with AYA to improve our understanding of their potential treatment approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12672-025-02103-3","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T04:20:17Z","timestamp":1743135617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of treatment outcomes between combined chemotherapy-radiation therapy (chemo-RT) and radiation therapy alone (RT) for intracranial germ cell tumors in adolescent and young adult patients (AYA)"],"prefix":"10.1007","volume":"16","author":[{"given":"Warissara","family":"Rongthong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Suntornpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kullathorn","family":"Thephamongkhol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teeradon","family":"Treechairusame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"issue":"7","key":"2103_CR1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1634\/theoncologist.2014-0009","volume":"19","author":"SJ Stoneham","year":"2014","unstructured":"Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, et al. Adolescents and young adults with a \u201crare\u201d cancer: getting past semantics to optimal care for patients with germ cell tumors. Oncologist. 2014;19(7):689\u201392.","journal-title":"Oncologist"},{"issue":"3","key":"2103_CR2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3340\/jkns.2018.0056","volume":"61","author":"JH Phi","year":"2018","unstructured":"Phi JH, Wang KC, Kim SK. Intracranial germ cell tumor in the molecular era. J Korean Neurosurg Soc. 2018;61(3):333\u201342.","journal-title":"J Korean Neurosurg Soc"},{"issue":"12","key":"2103_CR3","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/neuonc\/nox122","volume":"19","author":"G Calaminus","year":"2017","unstructured":"Calaminus G, Frappaz D, Kortmann RD, Krefeld B, Saran F, Pietsch T, et al. Outcome of patients with intracranial non-germinomatous germ cell tumors\u2014lessons from the SIOP-CNS-GCT-96 trial. Neuro Oncol. 2017;19(12):1661\u201372.","journal-title":"Neuro Oncol"},{"issue":"2","key":"2103_CR4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3171\/2020.6.JNS20638","volume":"135","author":"H Shimizu","year":"2021","unstructured":"Shimizu H, Motomura K, Ohka F, Aoki K, Tanahashi K, Hirano M, et al. Long-term survival in patients with primary intracranial germ cell tumors treated with surgery, platinum-based chemotherapy, and radiotherapy: a single-institution study. J Neurosurg. 2021;135(2):449\u201357.","journal-title":"J Neurosurg"},{"issue":"1","key":"2103_CR5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11060-017-2696-1","volume":"137","author":"WG Wang","year":"2018","unstructured":"Wang WG, Ye H, Chinnaiyan P. Practice patterns and survival outcomes of intracranial germinoma: an analysis of the National Cancer Database. J Neurooncol. 2018;137(1):77\u201382.","journal-title":"J Neurooncol"},{"issue":"3","key":"2103_CR6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.30755","volume":"141","author":"MJ Murray","year":"2017","unstructured":"Murray MJ, Bailey S, Heinemann K, Mann J, G\u00f6bel UK, Saran F, et al. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy. Int J Cancer. 2017;141(3):621\u201335.","journal-title":"Int J Cancer"},{"issue":"16","key":"2103_CR7","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1200\/JCO.2011.35.5602","volume":"29","author":"AM Geiger","year":"2011","unstructured":"Geiger AM, Castellino SM. Delineating the age ranges used to define adolescents and young adults. J Clin Oncol. 2011;29(16):e492\u20133.","journal-title":"J Clin Oncol"},{"issue":"10","key":"2103_CR8","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/cncr.26564","volume":"118","author":"YW Chen","year":"2012","unstructured":"Chen YW, Huang PI, Ho DM, Hu YW, Chang KP, Chiou SH, et al. Change in treatment strategy for intracranial Germinoma: long-term follow-up experience at a single institute. Cancer. 2012;118(10):2752\u201362.","journal-title":"Cancer"},{"issue":"1","key":"2103_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.radonc.2008.10.012","volume":"91","author":"J Cho","year":"2009","unstructured":"Cho J, Choi J-U, Kim D-S, Suh C-O. Low-dose craniospinal irradiation as a definitive treatment for intracranial germinoma. Radiother Oncol. 2009;91(1):75\u20139.","journal-title":"Radiother Oncol"},{"issue":"9","key":"2103_CR10","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1002\/cncr.22246","volume":"107","author":"Q-N Nguyen","year":"2006","unstructured":"Nguyen Q-N, Chang EL, Allen PK, Maor MH, Ater JL, Mahajan A, et al. Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure. Cancer. 2006;107(9):2228\u201336.","journal-title":"Cancer"},{"issue":"8","key":"2103_CR11","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1200\/JCO.1999.17.8.2585","volume":"17","author":"M Bamberg","year":"1999","unstructured":"Bamberg M, Kortmann R-D, Calaminus G, Becker G, Meisner C, Harms D, et al. Radiation therapy for intracranial Germinoma: results of the German cooperative prospective trials MAKEI 83\/86\/89. J Clin Oncol. 1999;17(8):2585.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2103_CR12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1012743707883","volume":"54","author":"M Matsutani","year":"2001","unstructured":"Matsutani M. Combined chemotherapy and radiation therapy for CNS germ cell tumors\u2013the Japanese experience. J Neurooncol. 2001;54(3):311\u20136.","journal-title":"J Neurooncol"},{"issue":"2","key":"2103_CR13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11060-019-03159-2","volume":"143","author":"AC Lo","year":"2019","unstructured":"Lo AC, Laperriere N, Hodgson D, Bouffet E, Nicholson J, McKenzie M, et al. Canadian patterns of practice for intracranial germ cell tumors in adolescents and young adults. J Neurooncol. 2019;143(2):289\u201396.","journal-title":"J Neurooncol"},{"issue":"6","key":"2103_CR14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/neuonc\/not019","volume":"15","author":"G Calaminus","year":"2013","unstructured":"Calaminus G, Kortmann R, Worch J, Nicholson JC, Alapetite C, Garr\u00e8 ML, et al. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol. 2013;15(6):788\u201396.","journal-title":"Neuro Oncol"},{"issue":"2","key":"2103_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijrobp.2019.10.020","volume":"106","author":"AC Lo","year":"2020","unstructured":"Lo AC, Hodgson D, Dang J, Tyldesley S, Bouffet E, Bartels U, et al. Intracranial germ cell tumors in adolescents and young adults: a 40-year multi-institutional review of outcomes. Int J Radiat Oncol Biol Phys. 2020;106(2):269\u201378.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2103_CR16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11060-020-03642-1","volume":"149","author":"J Wong","year":"2020","unstructured":"Wong J, Goddard K, Laperriere N, Dang J, Bouffet E, Bartels U, et al. Long term toxicity of intracranial germ cell tumor treatment in adolescents and young adults. J Neurooncol. 2020;149(3):523\u201332.","journal-title":"J Neurooncol"},{"issue":"34","key":"2103_CR17","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1200\/JCO.19.00701","volume":"37","author":"J Fangusaro","year":"2019","unstructured":"Fangusaro J, Wu S, MacDonald S, Murphy E, Shaw D, Bartels U, et al. Phase II trial of response-based radiation therapy for patients with localized CNS nongerminomatous germ cell tumors: a children\u2019s oncology group study. J Clin Oncol. 2019;37(34):3283\u201390.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2103_CR18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0094-0143(21)01175-7","volume":"4","author":"LH Einhorn","year":"1977","unstructured":"Einhorn LH, Donohue JP. Chemotherapy for disseminated testicular cancer. Urol Clin North Am. 1977;4(3):407\u201326.","journal-title":"Urol Clin North Am"},{"issue":"4","key":"2103_CR19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1096-911X(199804)30:4<217::AID-MPO3>3.0.CO;2-J","volume":"30","author":"JR Mann","year":"1998","unstructured":"Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Phillips M, et al. UKCCSG\u2019s germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours\u2014carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. Med Pediatr Oncol. 1998;30(4):217\u201327.","journal-title":"Med Pediatr Oncol"},{"key":"2103_CR20","unstructured":"Board PDQPTE. Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ\u00ae): Health Professional Version. PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2002."},{"key":"2103_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194847","author":"SHM Janssen","year":"2021","unstructured":"Janssen SHM, van der Graaf WTA, van der Meer DJ, Manten-Horst E, Husson O. Adolescent and young adult (AYA) cancer survivorship practices: an overview. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13194847.","journal-title":"Cancers (Basel)."},{"issue":"1","key":"2103_CR22","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1182\/blood-2023-185217","volume":"142","author":"CO Ramos Pe\u00f1afiel","year":"2023","unstructured":"Ramos Pe\u00f1afiel CO, Gallardo-Rodr\u00edguez AG, P\u00e9rez S\u00e1mano D, Martinez Moreno E, Cabrera Garc\u00eda \u00c1, Balderas Delgado C, et al. Comparison of two therapeutic approaches (pediatric vs. adult) for treating acute lymphoblastic leukemia. Experience of two centers in Mexico City. Blood. 2023;142(1):5894.","journal-title":"Blood"},{"issue":"6","key":"2103_CR23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/neuonc\/noab270","volume":"24","author":"U Bartels","year":"2021","unstructured":"Bartels U, Onar-Thomas A, Patel SK, Shaw D, Fangusaro J, Dhall G, et al. Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children\u2019s Oncology Group study. Neuro Oncol. 2021;24(6):974\u201383.","journal-title":"Neuro Oncol"},{"issue":"3","key":"2103_CR24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00432-019-03088-7","volume":"146","author":"S Denyer","year":"2020","unstructured":"Denyer S, Bhimani AD, Patil SN, Mudreac A, Behbahani M, Mehta AI. Treatment and survival of primary intracranial germ cell tumors: a population-based study using SEER database. J Cancer Res Clin Oncol. 2020;146(3):671\u201385.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"2103_CR25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/neuonc\/noab252","volume":"24","author":"D Frappaz","year":"2021","unstructured":"Frappaz D, Dhall G, Murray MJ, Goldman S, Faure Conter C, Allen J, et al. EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults. Neuro Oncol. 2021;24(4):516\u201327.","journal-title":"Neuro Oncol"},{"issue":"2","key":"2103_CR26","first-page":"202","volume":"7","author":"R Worawongsakul","year":"2020","unstructured":"Worawongsakul R, Sirachainan N, Rojanawatsirivej A, Boongird A, Singhsnaeh A, Swangsilpa T, et al. Carboplatin-based regimen in pediatric intracranial germ-cell tumors (IC-GCTs): effectiveness and ototoxicity. Neurooncol Pract. 2020;7(2):202\u201310.","journal-title":"Neurooncol Pract"},{"issue":"4","key":"2103_CR27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41591-022-01738-x","volume":"28","author":"CS Pramesh","year":"2022","unstructured":"Pramesh CS, Badwe RA, Bhoo-Pathy N, Booth CM, Chinnaswamy G, Dare AJ, et al. Priorities for cancer research in low- and middle-income countries: a global perspective. Nat Med. 2022;28(4):649\u201357.","journal-title":"Nat Med"},{"issue":"5","key":"2103_CR28","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jpeds.2013.06.024","volume":"163","author":"RV Sethi","year":"2013","unstructured":"Sethi RV, Marino R, Niemierko A, Tarbell NJ, Yock TI, MacDonald SM. Delayed diagnosis in children with intracranial germ cell tumors. J Pediatr. 2013;163(5):1448\u201353.","journal-title":"J Pediatr"},{"key":"2103_CR29","doi-asserted-by":"publisher","DOI":"10.21037\/pm-21-32","author":"A Zhang","year":"2021","unstructured":"Zhang A, Gao Y. Intracranial germ cell tumors in pediatric and adolescent patients in China: systematic review and meta-analysis. Pediatric Med. 2021. https:\/\/doi.org\/10.21037\/pm-21-32.","journal-title":"Pediatric Med"},{"key":"2103_CR30","unstructured":"Ehrlich BS, McNeil MJ, Pham LTD, Chen Y, Rivera J, Acuna C, et al. Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Oncol"},{"issue":"1","key":"2103_CR31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12020-018-1830-y","volume":"64","author":"N Qiao","year":"2019","unstructured":"Qiao N. Excess mortality after craniopharyngioma treatment: Are we making progress? Endocrine. 2019;64(1):31\u20137.","journal-title":"Endocrine"},{"issue":"7","key":"2103_CR32","doi-asserted-by":"crossref","first-page":"e913","DOI":"10.1097\/MPH.0000000000002116","volume":"43","author":"R Rajagopal","year":"2021","unstructured":"Rajagopal R, Leong SH, Jawin V, Foo JC, Ahmad Bahuri NF, Mun KS, et al. Challenges in the management of childhood intracranial germ cell tumors in middle-income countries: a 20-year retrospective review from a single tertiary center in Malaysia. J Pediatr Hematol Oncol. 2021;43(7):e913\u201323.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2103_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1114652","author":"F Zhao","year":"2023","unstructured":"Zhao F, Yang D, Li X. Effect of radiotherapy interruption on nasopharyngeal cancer. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2023.1114652.","journal-title":"Front Oncol"},{"issue":"1","key":"2103_CR34","first-page":"56","volume":"24","author":"G Calaminus","year":"2022","unstructured":"Calaminus G, Frappaz D, Ajithkumar T, M\u00fcller J-E, Zimmermann M, Conter CF, et al. GCT-12. SIOP CNS GCT II: High Risk (HR) CNS Non-germinomatous Germ Cell Tumours (NGGCT) treated with Dose intensified PEI \u2013 final results. Neuro-Oncol. 2022;24(1):56-i7.","journal-title":"Neuro-Oncol"},{"issue":"3","key":"2103_CR35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/pbc.20815","volume":"48","author":"C Kretschmar","year":"2007","unstructured":"Kretschmar C, Kleinberg L, Greenberg M, Burger P, Holmes E, Wharam M. Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children\u2019s Oncology Group. Pediatr Blood Cancer. 2007;48(3):285\u201391.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2103_CR36","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/neuonc\/noab270","volume":"24","author":"U Bartels","year":"2022","unstructured":"Bartels U, Onar-Thomas A, Patel SK, Shaw D, Fangusaro J, Dhall G, et al. Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children\u2019s Oncology Group study. Neuro Oncol. 2022;24(6):974\u201383.","journal-title":"Neuro Oncol"},{"issue":"11","key":"2103_CR37","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/neuonc\/noac057","volume":"24","author":"A Fonseca","year":"2022","unstructured":"Fonseca A, Faure-Conter C, Murray MJ, Fangusaro J, Bailey S, Goldman S, et al. Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): a pooled analysis of clinical trials. Neuro Oncol. 2022;24(11):1950\u201361.","journal-title":"Neuro Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02103-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T04:21:06Z","timestamp":1743135666000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02103-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2103"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02103-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"23 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"391"}}